Healthcare - Biotechnology - NASDAQ - US
$ 2.27
-7.72 %
$ 476 M
Market Cap
-1.46
P/E
Price Target
Average
737.00%
Revenue Forecast
Estimate
638.28%
EBIT
Estimate
35.58%
Net Income
Estimate
24.19%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Allogene Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for ALLO of $19 , with forecasts ranging from a low of $7 to a high of $55 .
ALLO Lowest Price Target
Wall Street Target
7 USD
208.37%
ALLO Average Price Target
Wall Street Target
19 USD
737.00%
ALLO Highest Price Target
Wall Street Target
55 USD
2322.91%
REVENUE FORECAST
Revenue Forecast Chart ALLO
EBIT FORECAST
EBIT Forecast Chart ALLO
NET INCOME FORECAST
Net Income Chart ALLO